Neoadjuvant chemoradiotherapy for resectable esophageal cancer: an in-depth study of randomized controlled trials and literature review

by Xiao-Feng Duan, Peng Tang, Zhen-Tao Yu
Published 2014-09-01

Role of radiation therapy in node‐negative esophageal cancer: A propensity‐matched analysis

by Hui‐Jiang Gao, Yu‐Cheng Wei, Lei Gong, Nan Ge, Bin Han, Guo‐Dong Shi, Zhen‐Tao Yu
Published 2020-10-01

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma

by Hui‐Jiang Gao, Yu‐Cheng Wei, Lei Gong, Nan Ge, Bin Han, Guo‐Dong Shi, Zhen‐Tao Yu
Published 2020-09-01

Adjuvant radiotherapy for patients with pathologic node‐negative esophageal carcinoma: A population based propensity matching analysis

by Hui‐Jiang Gao, Xiao‐Bin Shang, Lei Gong, Hong‐Dian Zhang, Peng Ren, Guo‐Dong Shi, Yu‐Cheng Wei, Zhen‐Tao Yu
Published 2020-02-01

Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study

by Xiaobin Zhang, Ben M. Eyck, Yang Yang, Jun Liu, Yin-Kai Chao, Ming-Mo Hou, Tsung-Min Hung, Qingsong Pang, Zhen-Tao Yu, Hongjing Jiang, Simon Law, Ian Wong, Ka-On Lam, Berend J. van der Wilk, Ate van der Gaast, Manon C. W. Spaander, Roelf Valkema, Sjoerd M. Lagarde, Bas P. L. Wijnhoven, J. Jan B. van Lanschot, Zhigang Li
Published 2020-03-01